Loading clinical trials...
Loading clinical trials...
This clinical trial was prospective, randomized, single-blind, 3-treatment arm, parallel treatment group, and active-controlled. , Multi-center, Phase 3 confirmatory clinical trial.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pharmbio Korea Co., Ltd.
NCT07222800 · Intestinal Neoplasms, Gastrointestinal Neoplasms, and more
NCT06290258 · Autism Spectrum Disorder, Gastrointestinal Diseases, and more
NCT05199532 · Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, and more
NCT07424469 · Gastrointestinal Diseases
NCT06112353 · Intestinal Disease
Kyung Hee University Hospital at Gangdong
Seoul, Gangdong-gu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions